These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 25203362)

  • 21. Survival and prognostic indicators in hepatitis B surface antigen-positive cirrhosis of the liver.
    de Jongh FE; Janssen HL; de Man RA; Hop WC; Schalm SW; van Blankenstein M
    Gastroenterology; 1992 Nov; 103(5):1630-5. PubMed ID: 1426884
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum albumin and platelet count but not portal pressure are predictive of death in patients with Child-Pugh A hepatitis C virus-related cirrhosis.
    Nahon P; Ganne-Carrié N; Degos F; Nahon K; Paries J; Grando V; Chaffaut C; Njapoum C; Christidis C; Trinchet JC; Chevret S; Beaugrand M
    Gastroenterol Clin Biol; 2005 Apr; 29(4):347-52. PubMed ID: 15864193
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictive role of serum procollagen III peptide and Knodell's index in survival prognosis of patients with hepatitis B virus liver cirrhosis.
    Babić Z; Bilić A; Babić D; Jagić V; Nikolić B; Sunić M
    Wien Klin Wochenschr; 2003 May; 115(9):302-8. PubMed ID: 12793031
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictors of survival in hepatitis B virus related decompensated cirrhosis on tenofovir therapy: an Indian perspective.
    Srivastava M; Rungta S; Dixit VK; Shukla SK; Singh TB; Jain AK
    Antiviral Res; 2013 Nov; 100(2):300-5. PubMed ID: 24012998
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simple scoring system for predicting cirrhosis in nonalcoholic fatty liver disease.
    Kessoku T; Ogawa Y; Yoneda M; Imajo K; Sumida Y; Eguchi Y; Fujii H; Hyogo H; Ono M; Suzuki Y; Kawaguchi T; Chayama K; Tanaka S; Fujimoto K; Anzai K; Saibara T; Sata M; Itoh Y; Nakajima A; Okanoue T;
    World J Gastroenterol; 2014 Aug; 20(29):10108-14. PubMed ID: 25110437
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of portal hemodynamics on Doppler ultrasonography for predicting decompensation and long-term outcomes in patients with cirrhosis.
    Kondo T; Maruyama H; Sekimoto T; Shimada T; Takahashi M; Okugawa H; Yokosuka O
    Scand J Gastroenterol; 2016; 51(2):236-44. PubMed ID: 26357874
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic Performance of Shear Wave Elastography for Predicting Esophageal Varices in Patients With Compensated Liver Cirrhosis.
    Kim TY; Kim TY; Kim Y; Lim S; Jeong WK; Sohn JH
    J Ultrasound Med; 2016 Jul; 35(7):1373-81. PubMed ID: 27208198
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatic Venous Pressure Gradient Predicts Long-Term Mortality in Patients with Decompensated Cirrhosis.
    Kim TY; Lee JG; Sohn JH; Kim JY; Kim SM; Kim J; Jeong WK
    Yonsei Med J; 2016 Jan; 57(1):138-45. PubMed ID: 26632394
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comparison of the Model for End-stage Liver Disease and hepatic venous pressure gradient for predicting survival in patients with decompensated liver cirrhosis].
    Lee SH; Park SH; Kim GW; Lee WJ; Hong WK; Ryu MS; Park KT; Lee MY; Lee CW; Kim JH; Kim YM; Kim SJ; Baik GH; Kim JB; Kim DJ
    Korean J Hepatol; 2009 Sep; 15(3):350-6. PubMed ID: 19783884
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adrenal insufficiency in decompensated cirrhotic patients without infection: prevalence, predictors and impact on mortality.
    Nandish HK; Arun CS; Nair HR; Gopalakrishna R; Kumar H; Venu RP
    J R Coll Physicians Edinb; 2019 Dec; 49(4):277-281. PubMed ID: 31808452
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Competing risks and prognostic stages of cirrhosis: a 25-year inception cohort study of 494 patients.
    D'Amico G; Pasta L; Morabito A; D'Amico M; Caltagirone M; Malizia G; Tinè F; Giannuoli G; Traina M; Vizzini G; Politi F; Luca A; Virdone R; Licata A; Pagliaro L
    Aliment Pharmacol Ther; 2014 May; 39(10):1180-93. PubMed ID: 24654740
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Survival and prognostic indicators in compensated and decompensated cirrhosis.
    D'Amico G; Morabito A; Pagliaro L; Marubini E
    Dig Dis Sci; 1986 May; 31(5):468-75. PubMed ID: 3009109
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thick Fibrous Septa on Liver Biopsy Specimens Predict the Development of Decompensation in Patients With Compensated Cirrhosis.
    Jain D; Sreenivasan P; Inayat I; Deng Y; Ciarleglio MM; Garcia-Tsao G
    Am J Clin Pathol; 2021 Oct; 156(5):802-809. PubMed ID: 33940622
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of telbivudine efficacy in treatment-naive patients with hepatitis B virus-related compensated and decompensated cirrhosis in 96 weeks.
    Yang X; Li J; Zhou L; Liu J; Wang J; Lu W
    Eur J Gastroenterol Hepatol; 2014 Apr; 26(4):396-403. PubMed ID: 24569820
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the effect of BCAA granules on between decompensated and compensated cirrhosis.
    Habu D; Nishiguchi S; Nakatani S; Lee C; Enomoto M; Tamori A; Takeda T; Ohfuji S; Fukushima W; Tanaka T; Kawamura E; Shiomi S
    Hepatogastroenterology; 2009; 56(96):1719-23. PubMed ID: 20214224
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Statins Are Associated With a Decreased Risk of Decompensation and Death in Veterans With Hepatitis C-Related Compensated Cirrhosis.
    Mohanty A; Tate JP; Garcia-Tsao G
    Gastroenterology; 2016 Feb; 150(2):430-40.e1. PubMed ID: 26484707
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New concepts on the clinical course and stratification of compensated and decompensated cirrhosis.
    D'Amico G; Morabito A; D'Amico M; Pasta L; Malizia G; Rebora P; Valsecchi MG
    Hepatol Int; 2018 Feb; 12(Suppl 1):34-43. PubMed ID: 28681347
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic value of C-reactive protein in cirrhosis: external validation from the CANONIC cohort.
    Cervoni JP; Amorós À; Bañares R; Luis Montero J; Soriano G; Weil D; Moreau R; Pavesi M; Thévenot T; Di Martino V;
    Eur J Gastroenterol Hepatol; 2016 Sep; 28(9):1028-34. PubMed ID: 27271159
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prediction of large esophageal varices in patients with cirrhosis of the liver using clinical, laboratory and imaging parameters.
    Sharma SK; Aggarwal R
    J Gastroenterol Hepatol; 2007 Nov; 22(11):1909-15. PubMed ID: 17914969
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Albumin and magnetic resonance imaging-liver volume to identify hepatitis B-related cirrhosis and esophageal varices.
    Li H; Chen TW; Li ZL; Zhang XM; Li CJ; Chen XL; Chen GW; Hu JN; Ye YQ
    World J Gastroenterol; 2015 Jan; 21(3):988-96. PubMed ID: 25624735
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.